Skip to content

Cervicovaginal microbiome in women with transient and persistent high-risk HPV infection

Exploring the association of cervicovaginal microbiome with transient and persistent high-risk HPV infection and cervical precancerous lesions - Nil

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/10/059330
Enrollment
90
Registered
2023-10-31
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B977- Papillomavirus as the cause of diseases classified elsewhere

Interventions

Intervention1: Nil: Nil

Sponsors

ICMR National Institute for Research in Reproductive and Child health
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: • Sexually active women of age (30-50) years • Provide informed consent

Exclusion criteria

Exclusion criteria: 1. History of cervical cancer 2. Have had a total hysterectomy 3. Are pregnant or have been pregnant in the last month 4. History of diabetes, innate or acquired immunodeficiency, concomitant neoplastic diseases • Chronic inflammatory diseases/infections including aerobic vaginitis and other sexually transmitted diseases, • Corticosteroid or immune therapy • vagina douching within last 2 days • vaginal intercourse within last 3 days • systemic application of antifungal agents or antibiotics or pessaries within last 14 days of sampling

Design outcomes

Primary

MeasureTime frame
•Knowing the composition cervicovaginal virome including bacteriophages in healthy HPV negative women •Documentation of possible association of cervicovaginal microbiome and cytokine profiles with transient and persistent HPV infectionTimepoint: 0, 6 and 12 months

Secondary

MeasureTime frame
• Identification of microbial fingerprints that might be potentially utilized as biomarker for HPV persistence • The data generated may serve as an useful information for modification of vaginal microbiome to reduce progression of HPV infection Timepoint: longterm

Countries

India

Contacts

Public ContactDr Kiran Munne

ICMR National Institute for Research in reproductive and child health

munnek@nirrh.res.in09923334435

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026